Evaluation of Myocardial Damage After Electroconvulsive Therapy: Analyses of High-Sensitive Cardiac Troponin I and N-Terminal pro-B-type Natriuretic Peptide

Abstract

Electroconvulsive therapy (ECT) is a remarkably safe procedure. However, there might exist a subgroup of patients with an increased risk for cardiovascular events. The cardiac-specific enzymes high-sensitive cardiac troponin I (hscTnI) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) were measured before and after ECT in 23 patients. No relevant increase of hscTnI after ECT was found. Mean NT-proBNP levels were higher after ECT and in three patients a new NT-proBNP elevation after ECT was identified. In conclusion, our small study did not find any evidence for myocardial damage due to ECT by measuring hsTnI, but an increase of NT-proBNP, whose clinical relevance could only be speculated, yet.

Key words

Electroconvulsive therapy - troponin - safety - side effects

• References

• 1 Torring N, Sanghani SN, Petrides G. et al. The mortality rate of electroconvulsive therapy: A systematic review and pooled analysis. Acta Psychiatr Scand 2017; 135: 388-397
• 2 Stoudemire A. Cardiovascular morbidity and ECT. Am J Psychiatry 1995; 152: 1697-1698
• 3 Steiner LA, Drop LJ, Castelli I. et al. Diagnosis of myocardial injury by real-time recording of ST segments of the electrocardiogram in a patient receiving general anesthesia for electroconvulsive therapy. Anesthesiology 1993; 79: 383-388
• 4 Gould L, Gopalaswamy C, Chandy F. et al. Electroconvulsive therapy-induced ECG changes simulating a myocardial infarction. Arch Intern Med 1983; 143: 1786-1787
• 5 Celano CM, Torri A, Seiner S. Takotsubo cardiomyopathy after electroconvulsive therapy: A case report and review. J ECT 2011; 27: 221-223
• 6 Beach SR, Wichman CL, Canterbury RJ. Takotsubo cardiomyopathy after electroconvulsive therapy. Psychosomatics 2010; 51: 432-436
• 7 Kellner CH, Husain MM, Knapp RG. et al. Right unilateral ultrabrief pulse ECT in geriatric depression: Phase 1 of the PRIDE study. Am J Psychiatry 2016; 173: 1101-1109
• 8 Hoyer C, Kranaster L, Janke C. et al. Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: A retrospective study. Eur Arch Psychiatry Clin Neurosci 2014; 264: 255-261
• 9 Kranaster L, Kammerer-Ciernioch J, Hoyer C. et al. Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: A retrospective study. Eur Arch Psychiatry Clin Neurosci 2011; 261: 575-582
• 10 Duma A, Pal S, Johnston J. et al. High-sensitivity cardiac troponin elevation after electroconvulsive therapy: A prospective, observational cohort study. Anesthesiology 2017; 126: 643-652
• 11 Luchner A, Weidemann A, Willenbrock R. et al. Improvement of the cardiac marker N-terminal-pro brain natriuretic peptide through adjustment for renal function: A stratified multicenter trial. Clin Chem Lab Med 2010; 48: 121-128
• 12 Ponikowski P, Voors AA, Anker SD. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal 2016; 37: 2129-2200
• 13 Landesberg G, London MJ. The enigma of postoperative troponin elevation. Anesth Analg 2016; 123: 5-7
• 14 Cantor WJ, Newby LK, Christenson RH. et al. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol 2002; 39: 1738-1744
• 15 Martinez MW, Rasmussen KG, Mueller PS. et al. Troponin elevations after electroconvulsive therapy: The need for caution. The American Journal of Medicine 2011; 124: 229-234
• 16 Kim YJ, Shin YO, Lee JB. et al. The effects of running a 308 km ultra-marathon on cardiac markers. Eur J Sport Sci 2014; 14 (Suppl. 01) S92-S97